Rx-to-OTC switches sales value is approximate to total US$ 35 Billion in 2021 and Exhibiting 5.3% CA

Rx-to-OTC switches refer to the transition from proven prescription drugs to nonprescription, OTC status. According to a report by Future Market Insights (FMI), the global Rx-to-OTC switches market was valued at US$ 33 Bn in 2020 and is predicted to expand at a CAGR of over 5% during the forecast period (2021–2031)....

Related Keywords

China ,Dubai ,Dubayy ,United Arab Emirates ,United States ,India ,America ,Debashish Roy ,Lomba Subsidiary Of Bausch Health ,Glaxosmithkline ,Bayer Ag ,Drug Administration ,Arbor Pharmaceuticals ,Market Research Expert ,Merck Kga ,Astrazeneca ,Merck Kgaa ,Key Companies ,Johnson ,Future Market Insights ,Free Sample Report ,Bausch Health ,Questions Answered ,North America ,East Asia ,Market Insights ,Lakes Towers ,Sales Enquiries ,Media Enquiries ,